Scientists at the University of Sussex in the UK are closer to developing a new blood test for identifying the most aggressive form of brain tumour.
University of Sussex cancer cell signalling professor Georgios Giamas’ team has identified distinctive biomarkers in patient blood samples that may signal the presence of glioblastoma, the most common high-grade primary brain tumour in adults.
In collaboration with University Hospitals Sussex consultant neurosurgeon and spinal surgeon Giles Critchley, the team identified biomarkers within extracellular vesicles, which are small particles secreted by all cells carrying different information, such as proteins or DNA.
